Tiposi

Tiposi operates at the intersection of medical devices, sensor hardware, digital health, and AI-enabled diagnostics. Its stated differentiation is the use of low-frequency, low-power radar to collect data without intrusive contact, with applications including vital-sign monitoring, personal safety, environmental monitoring, and automation. The company also presents intelligent imaging and brain-health assessment as areas of focus, including rapid stroke detection. This combination gives Tiposi a potentially broad application surface, but it also makes the company's primary market position difficult to define from available public information. Tiposi's two granted patents, CES 2026 AI recognition, and stated RFIC, wireless communications, and digital signal-processing capabilities provide evidence of technical activity. Its differentiation therefore appears to rest more on integrated sensing and privacy-preserving data collection than on a clearly documented single clinical indication.

Tiposi's trajectory appears to be driven by expansion from core low-power radar sensing into broader healthcare and intelligent-imaging applications. The company describes a single-chip CMOS Vital Radar Sensor capable of supporting human vital-sign monitoring, AI analysis, security, environmental monitoring, and automation. Website materials additionally emphasize rapid stroke detection, brain-health assessment, connected hardware, and clinical research, suggesting an effort to move from component-level sensing toward complete medical-device systems. The company has maintained CEO Shih Mo in leadership since January 2019 and currently lists an employee range of approximately 11 to 50 people. Recognition as a 2026 CES Innovation Awards Honoree provides a recent visibility milestone, while two granted patents indicate some intellectual-property development.